Clinical Trial Update: A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Vidutolimod in combination with cemiplimab for adults with advanced or metastatic cancers was terminated, with results posted on 2025…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma
• Cutaneous Squamous Cell Carcinoma
• Merkel Cell Carcinoma
• Non-small Cell Lung Cancer
• Oropharyngeal Squamous Cell Carcinoma
• Triple-negative Breast Cancer

Drugs mentioned

• Cemiplimab (cemiplimab)
• Vidutolimod

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Merkel Cell Carcinoma, Cutaneous Squamous Cell Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2025-12-05